title: Guidelines on Testicular Cancer: 2015 Update.
abstract: BACKGROUND
  This is an update of the previous European Association of Urology testis cancer guidelines published in 2011, which included major changes in the diagnosis and treatment of germ cell tumours.
  
  
  OBJECTIVE
  To summarise latest developments in the treatment of this rare disease. Recommendations have been agreed within a multidisciplinary working group consisting of urologists, medical oncologists, and radiation oncologists.
  
  
  METHODS
  A semi-structured literature search up to February 2015 was performed to update the recommendations. In addition, this document was subjected to double-blind peer review before publication.
  
  
  RESULTS
  This publication focuses on the most important changes in treatment recommendations for clinical stage I disease and the updated recommendations for follow-up.
  
  
  CONCLUSIONS
  Most changes in the recommendations will lead to an overall reduction in treatment burden for patients with germ cell tumours. In advanced stages, treatment intensification is clearly defined to further improve overall survival rates.
  
  
  RESULTS
  This is an update of a previously published version of the European Association of Urology guidelines for testis cancer, and includes new recommendations for clinical stage I disease and revision of the follow-up recommendations. Patients should be fully informed of all the treatment options available to them.
authors: Department of Urology, Medical Faculty, Düsseldorf University, Düsseldorf, Germany. Electronic address: urologie@uni-duesseldorf.de.
authors: Peter
authors: P
authors: Albers
authors: Department of Urology, Mistelbach, Austria.
authors: Walter
authors: W
authors: Albrecht
authors: Department of Pathology, Fundacio Puigvert, Barcelona, Spain.
authors: Ferran
authors: F
authors: Algaba
authors: Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Universitätskliniken Eppendorf, Hamburg, Germany.
authors: Carsten
authors: C
authors: Bokemeyer
authors: Department of Oncology-Pathology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
authors: Gabriella
authors: G
authors: Cohn-Cedermark
authors: Department of Medicine, University of Paris XI, Villejuif, France.
authors: Karim
authors: K
authors: Fizazi
authors: Academic Unit of Radiotherapy and Oncology, Royal Marsden NHS Trust and The Institute of Cancer Research, Sutton, UK.
authors: Alan
authors: A
authors: Horwich
authors: Department of Urology, Amsterdam Medical Centre, Amsterdam University, Amsterdam, The Netherlands.
authors: Maria Pilar
authors: MP
authors: Laguna
authors: Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
authors: Nicola
authors: N
authors: Nicolai
authors: Health Sciences, Høgskolen i Buskerud og Vestfold, Kongsberg, Norway.
authors: Jan
authors: J
authors: Oldenburg
mesh_terms: D003663:Decision Trees; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D013736:Testicular Neoplasms / Q000175:diagnosis* / Q000628:therapy*
keywords: Chemotherapy; EAU guidelines; Follow-up; Germ cell tumour; Metastatic disease; Relapse; Retroperitoneal lymph node dissection; Risk-adapted treatment; Testis cancer